Plasmacytoma — Trials

Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04065308	Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma(Dara_DCEP)	unknown	Phase 2	33	Seoul National University HospitalOTHER	1	Aug 22, 2019	clinicaltrials
NCT04008888	a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients	unknown	N/A	50	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Jul 5, 2019